Skip to main content
Figure 1 | Trials

Figure 1

From: The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial

Figure 1

Trial flow. Patients scheduled for caesarean section or developing postpartum haemorrhage following vaginal delivery will be screened for inclusion/exclusion and asked for consent to participate. Baseline blood samples are taken before intervention and patients are randomised to either intervention (fibrinogen concentrate) or placebo (saline). Haemostatic monitoring (blood samples) is performed 15 minutes, 4 hours and 24 hours post-intervention together with a clinical status.

Back to article page